U
Micron Solutions, Inc.
MICRD
$0.0001
-$0.0001-50.00%
D
Sell
6/26/2020Upgraded
Micron Solutions, Inc. (MICR) was upgraded to D from D- on 6/26/2020 due to a large increase in the growth index. Earnings per share increased from -$0.2222 to -$0.098, EBIT increased 53.64% from -$416.7 to -$193.2, and total revenue increased 45.75% from $3.59M to $5.23M.
Micron Solutions, Inc. (MICR) was upgraded to D from D- on 6/26/2020 due to a large increase in the growth index. Earnings per share increased from -$0.2222 to -$0.098, EBIT increased 53.64% from -$416.7 to -$193.2, and total revenue increased 45.75% from $3.59M to $5.23M.
D
Sell
4/22/2020Downgrade
Micron Solutions, Inc. (MICR) was downgraded to D- from D on 4/22/2020 due to a decline in the total return index, volatility index and solvency index.
Micron Solutions, Inc. (MICR) was downgraded to D- from D on 4/22/2020 due to a decline in the total return index, volatility index and solvency index.
D
Sell
4/6/2020Upgraded
Micron Solutions, Inc. (MICR) was upgraded to D from D- on 4/6/2020 due to an increase in the volatility index.
Micron Solutions, Inc. (MICR) was upgraded to D from D- on 4/6/2020 due to an increase in the volatility index.
D
Sell
3/23/2020Downgrade
Micron Solutions, Inc. (MICR) was downgraded to D- from D on 3/23/2020 due to a decline in the total return index and volatility index.
Micron Solutions, Inc. (MICR) was downgraded to D- from D on 3/23/2020 due to a decline in the total return index and volatility index.
D
Sell
3/2/2020Upgraded
Micron Solutions, Inc. (MICR) was upgraded to D from D- on 3/2/2020 due to an increase in the total return index and volatility index.
Micron Solutions, Inc. (MICR) was upgraded to D from D- on 3/2/2020 due to an increase in the total return index and volatility index.
D
Sell
10/22/2019Downgrade
Micron Solutions, Inc. (MICR) was downgraded to D- from D on 10/22/2019 due to a decline in the total return index and volatility index.
Micron Solutions, Inc. (MICR) was downgraded to D- from D on 10/22/2019 due to a decline in the total return index and volatility index.
D
Sell
10/7/2019Upgraded
Micron Solutions, Inc. (MICR) was upgraded to D from D- on 10/7/2019 due to an increase in the volatility index.
Micron Solutions, Inc. (MICR) was upgraded to D from D- on 10/7/2019 due to an increase in the volatility index.
D
Sell
9/5/2019Downgrade
Micron Solutions, Inc. (MICR) was downgraded to D- from D on 9/5/2019 due to a decline in the efficiency index, solvency index and total return index. Total capital declined 10.16% from $10.27M to $9.23M, and debt to equity increased from 1.83 to 1.84.
Micron Solutions, Inc. (MICR) was downgraded to D- from D on 9/5/2019 due to a decline in the efficiency index, solvency index and total return index. Total capital declined 10.16% from $10.27M to $9.23M, and debt to equity increased from 1.83 to 1.84.
D
Sell
4/11/2018Upgraded
Micron Solutions, Inc. (MICR) was upgraded to D from D- on 4/11/2018 due to an increase in the total return index and volatility index.
Micron Solutions, Inc. (MICR) was upgraded to D from D- on 4/11/2018 due to an increase in the total return index and volatility index.
D
Sell
3/27/2018Downgrade
Micron Solutions, Inc. (MICR) was downgraded to D- from D on 3/27/2018 due to a major decline in the total return index, volatility index and growth index. EBIT declined 569.98% from -$42.3 to -$283.4, earnings per share declined from -$0.0641 to -$0.1287, and total revenue declined 7.52% from $4.91M to $4.54M.
Micron Solutions, Inc. (MICR) was downgraded to D- from D on 3/27/2018 due to a major decline in the total return index, volatility index and growth index. EBIT declined 569.98% from -$42.3 to -$283.4, earnings per share declined from -$0.0641 to -$0.1287, and total revenue declined 7.52% from $4.91M to $4.54M.
D
Sell
9/21/2016Downgrade
Arrhythmia Research Technology Inc. (HRT) was downgraded to D from D+ on 9/21/2016 due to a decline in the total return index.
Arrhythmia Research Technology Inc. (HRT) was downgraded to D from D+ on 9/21/2016 due to a decline in the total return index.
D
Sell
9/6/2016Upgraded
Arrhythmia Research Technology Inc. (HRT) was upgraded to D+ from D on 9/6/2016 due to an increase in the growth index, efficiency index and valuation index. Operating cash flow increased 815.61% from -$55.1 to $394.3, EBIT increased 138.59% from -$324.7 to $125.3, and net income increased 116.17% from -$384.1 to $62.1.
Arrhythmia Research Technology Inc. (HRT) was upgraded to D+ from D on 9/6/2016 due to an increase in the growth index, efficiency index and valuation index. Operating cash flow increased 815.61% from -$55.1 to $394.3, EBIT increased 138.59% from -$324.7 to $125.3, and net income increased 116.17% from -$384.1 to $62.1.
D
Sell
3/11/2016Downgrade
Arrhythmia Research Technology Inc. (HRT) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
Arrhythmia Research Technology Inc. (HRT) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
D
Sell
2/2/2016Downgrade
Arrhythmia Research Technology Inc. (HRT) was downgraded to D+ from C- on 2/2/2016 due to a decline in the volatility index and total return index.
Arrhythmia Research Technology Inc. (HRT) was downgraded to D+ from C- on 2/2/2016 due to a decline in the volatility index and total return index.
C
Hold
12/29/2015Upgraded
Arrhythmia Research Technology Inc. (HRT) was upgraded to C- from D+ on 12/29/2015 due to an increase in the total return index.
Arrhythmia Research Technology Inc. (HRT) was upgraded to C- from D+ on 12/29/2015 due to an increase in the total return index.
D
Sell
12/14/2015Downgrade
Arrhythmia Research Technology Inc. (HRT) was downgraded to D+ from C- on 12/14/2015 due to a decline in the total return index and solvency index.
Arrhythmia Research Technology Inc. (HRT) was downgraded to D+ from C- on 12/14/2015 due to a decline in the total return index and solvency index.
C
Hold
11/19/2015Downgrade
Arrhythmia Research Technology Inc. (HRT) was downgraded to C- from C on 11/19/2015 due to a major decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.04 to -$0.1, net income declined 330.56% from $115.2 to -$265.6, and EBIT declined 136.16% from $181.7 to -$65.7.
Arrhythmia Research Technology Inc. (HRT) was downgraded to C- from C on 11/19/2015 due to a major decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.04 to -$0.1, net income declined 330.56% from $115.2 to -$265.6, and EBIT declined 136.16% from $181.7 to -$65.7.
C
Hold
6/8/2015Downgrade
Arrhythmia Research Technology Inc. (HRT) was downgraded to C from C+ on 6/8/2015 due to a large decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.6 to 0.61.
Arrhythmia Research Technology Inc. (HRT) was downgraded to C from C+ on 6/8/2015 due to a large decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.6 to 0.61.
C
Hold
1/22/2015Upgraded
Arrhythmia Research Technology Inc. (HRT) was upgraded to C+ from C on 1/22/2015 due to a large increase in the total return index and solvency index.
Arrhythmia Research Technology Inc. (HRT) was upgraded to C+ from C on 1/22/2015 due to a large increase in the total return index and solvency index.
C
Hold
12/4/2014Downgrade
Arrhythmia Research Technology Inc. (HRT) was downgraded to C from C+ on 12/4/2014 due to a decline in the total return index, valuation index and volatility index.
Arrhythmia Research Technology Inc. (HRT) was downgraded to C from C+ on 12/4/2014 due to a decline in the total return index, valuation index and volatility index.
C
Hold
11/19/2014Upgraded
Arrhythmia Research Technology Inc. (HRT) was upgraded to C+ from C- on 11/19/2014 due to a major increase in the valuation index, efficiency index and volatility index.
Arrhythmia Research Technology Inc. (HRT) was upgraded to C+ from C- on 11/19/2014 due to a major increase in the valuation index, efficiency index and volatility index.
C
Hold
10/3/2014Downgrade
Arrhythmia Research Technology Inc. (HRT) was downgraded to C- from C on 10/3/2014 due to a noticeable decline in the total return index.
Arrhythmia Research Technology Inc. (HRT) was downgraded to C- from C on 10/3/2014 due to a noticeable decline in the total return index.
C
Hold
8/15/2014Upgraded
Arrhythmia Research Technology Inc. (HRT) was upgraded to C from C- on 8/15/2014 due to a noticeable increase in the growth index, total return index and solvency index. Operating cash flow increased 3,616.59% from $21.7 to $806.5, debt to equity declined from 0.79 to 0.69, and total revenue increased 3.71% from $6.03M to $6.25M.
Arrhythmia Research Technology Inc. (HRT) was upgraded to C from C- on 8/15/2014 due to a noticeable increase in the growth index, total return index and solvency index. Operating cash flow increased 3,616.59% from $21.7 to $806.5, debt to equity declined from 0.79 to 0.69, and total revenue increased 3.71% from $6.03M to $6.25M.
C
Hold
3/21/2014Upgraded
Arrhythmia Research Technology Inc. (HRT) was upgraded to C- from D+ on 3/21/2014 due to a significant increase in the volatility index, total return index and efficiency index. Total capital increased 11.74% from $10.45M to $11.68M.
Arrhythmia Research Technology Inc. (HRT) was upgraded to C- from D+ on 3/21/2014 due to a significant increase in the volatility index, total return index and efficiency index. Total capital increased 11.74% from $10.45M to $11.68M.
OTC PK
02/26/2025 9:45AM Eastern
Quotes delayed
